JASPER THERAPEUTICS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
JASPER THERAPEUTICS, INC. (JSPR) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$155.56 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-13
- JASPER THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was -$155.56K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 5 month |
|---|---|---|
| 2020-03-31 | -$155.56K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.21M 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |